LC-MS-MS method for simultaneous determination of THCCOOH and THCCOOH-glucuronide in urine: Application to workplace confirmation tests

Forensic Science International

Volumn 204, Issue 1-3, 2011, Pages 67-73

  Felli, M ^a   Martello, S ^a   Chiarotti, M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Cannabinoids; CTHC glucuronide; LC MS MS analysis; Urine; Workplace

Indexed keywords

ACETONITRILE; FORMIC ACID; GLUCURONIDE; METHANOL; TETRAHYDROCANNABINOL; TETRAHYDROCANNABINOLIC ACID;

ARTICLE; CONTROLLED STUDY; HUMAN; HYDROLYSIS; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; SCREENING TEST; URINALYSIS; URINE LEVEL; VALIDATION PROCESS; WORKPLACE;

EID: 78650877521     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.05.004     Document Type: Article

References (25)

1. Leggett T. A review of the world cannabis situation. Bull. Narc. 2006, 58(1-2):1-155. United Nations Office on Drugs and Crime.
2. United Nations Office on Drugs and Crime World Drug Report 2008 2008, Available from: http://www.unodc.org/unodc/en/world_drug_report.html.
3. The State of the Drugs Problem in Europe Annual Report 2008 2008, European Monitoring Centre for Drugs and Drug Addiction.
4. Drug Use, Impaired Driving and Traffic Accidents Insights series 2008 2008, European Monitoring Centre for Drugs and Drug Addiction.
5. Verstraete A.G., Pierce A. Workplace drug testing in Europe. Forensic Sci. Int. 2001, 121:2-6.
6. Provvedimento n., 99/CU 30/10/2007 (G.U. 266 del 15/11/2007).
7. Accordo Stato/Regioni rep. Atti n., 178 del 18/9/2008.
8. European Laboratory Guidelines for Legally Defensible Workplace Drug Testing 2002, Available from: http://www.ewdts.org/guidelines.html.
9. Bertol E., Lodi F., Mari F., Marozzi E. Trattato di Tossicologia Forense. CEDAM 2000.
10. Goodwin R.S., Darwin W.D., Chiang C.N., Shih M., Li S.H., Huestis M.A. Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. J. Anal. Toxicol. 2008, 32(8):562-569.
11. Musshoff F., Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther. Drug Monit. 2006, 28:155-163.
12. Teixeira H., Verstraete A., Proença P., Corte-Real F., Monsanto P., Vieira D.N. Validated method for the simultaneous determination of delta9-THC and delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization. Forensic Sci. Int. 2007, 170(2-3):148-155.
13. Moore C., Rana S., Coulter C., Day D., Vincent M., Soares J. Detection of conjugated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J. Anal. Toxicol. 2007, 31(4):187-194.
14. Abraham T.T., Lowe R.H., Pirnay S.O., Darwin W.D., Huestis M.A. Simultaneous GC-EI-MS determination of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis. J. Anal. Toxicol. 2007, 31(8):477-485.
15. Boldis O., Kocsis G., Gachályi A., Furész J. Gas chromatography-mass spectrometry-single ion monitoring measurement of 11-nor-delta 9-tetrahydrocannabinol-carboxylic acid in urine. J. Chromatogr. Sci. 2003, 41(4):190-194.
16. Stephanson N., Josefsson M., Kronstrand R., Beck O.J. Accurate identification and quantification of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine drug testing: evaluation of a direct high efficiency liquid chromatographic-mass spectrometric method. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2008, 871(1):101-108.
17. Maralikova B., Weinmann W. Simultaneous determination of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 2004, 39(5):526-531.
18. Weinmann W., Vogt S., Goerke R., Müller C., Bromberger A. Simultaneous determination of THC-COOH and THC-COOH-glucuronide in urine samples by LC/MS/MS. Forensic Sci. Int. 2000, 113(1-3):381-387.
19. Tai S.S., Welch M.J. Determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in a urine-based standard reference material by isotope-dilution liquid chromatography-mass spectrometry with electrospray ionization. J. Anal. Toxicol. 2000, 24(6):385-389.
20. Breidahl T., Andreasen K. Determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine using high-performance liquid chromatography and electrospray ionization mass spectrometry. J. Chromatogr. B 1999, 732:155-164.
21. Lowe R.H., Karschner E.L., Schwilke E.W., Barnes A.J., Huestis M.A. Simultaneous quantification of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J. Chromatogr. A 2007, 1163(1-2):318-327.
22. EURACHEM The Fitness for Purpose of Analytical Methods-A Laboratory Guide to Method Validation and Related Topics 1998.
23. Peters F.T., Drummer O.H., Musshoff F. Validation of new methods. Forensic Sci. Int. 2007, 165:216-224.
24. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75(13):3019-3030.
25. Rivier L. Criteria for the identification of compounds by liquid chromatography-mass spectrometry and liquid chromatography-multiple mass spectrometry in forensic toxicology and doping analysis. Anal. Chim. Acta 2003, 492:69-82.